ArticleVeterinary medicine and science2025
Disease Prevalence, Usage of Aquaculture Medicinal Products and Their Sustainable Alternatives in Freshwater Aquaculture of North-Central Bangladesh.
Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Innovative Field Applications of Probiotics, Prebiotics, and Medicinal Plant Products for Disease Control in Aquaculture.Journal of fish diseases · 2026Review
- Review
- Knowledge, attitudes, and practices on antibiotic use and resistance among fish farmers in Kwara State, North Central, Nigeria.BMC veterinary research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe use and abuse of aquaculture medicinal products (AMPs) has increased throughout the globe to enhance fish production and maximize profits. This study aimed to investigate the status of disease prevalence and usage of AMPs in aquaculture operations in North-Central Bangladesh, a region famous for its significant carp and catfish production within the Asian subcontinent. Farmers in this area are recognized for their innovative approaches to aquaculture.
methodsData were collected through pretested questionnaire interviews and participatory rural appraisal (PRA) tools.
resultsAmong the 90 surveyed grow-out farmers, the majority practiced mixed cultures of carps, Nile tilapia and catfish (primarily Pangasius) where diseases such as epizootic ulcerative syndrome (EUS), saprolegniasis, streptococcosis, tail and fin rot and bacillary necrosis were common. Despite the widespread use of AMPs, their efficacy is often limited, and their overuse can contribute to the development of antibiotic-resistant bacteria and environmental pollution. Additionally, the extra-label drug use (ELDU) has become an issue that results in controversial application of drugs by fish farmers. All together 142 AMPs of different groups were marketed by 24 companies, including antibiotics, disinfectants, nutritional supplements, probiotics, gas remover and salt. Among these, 3 groups of antibiotics with 11 active ingredients were identified, sold under 17 trade names in drug retail outlets. These antibiotics, originally intended for veterinary or poultry use, were often misapplied in aquaculture, raising concerns about ELDU practices. Due to the limited efficacy of many of these antibiotics, farmers adopted alternative approaches such as in-pond probiotics and fermented products. It was revealed that 12% (11 out of 90) of the farmers were using these alternatives that led to approximately 20% approved fish growth with a cost reduction up to 30% compared to the conventional culture cycles. Farmers also reported a reduction in disease outbreaks in ponds managed with these alternatives.
conclusionsPromotion of sustainable and responsible practices is essential for the long-term growth of aquaculture industry. It is expected that the use of probiotics and fermented products can reduce the reliance on conventional AMPs, thereby contributing to enhanced food security and economic development in Bangladesh.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.